Black women with early hormone receptor (HR)–positive breast cancer appear to have significantly worse survival compared with White women, according to a retrospective analysis led by Gelareh Sadigh, MD (above), of the Emory University School of Medicine of a study of more than 10,000 women.
Black women were about 40 percent more likely to have a shorter time before a relapse of their cancer and were about 50 percent more likely to have a shorter survival than White women. These differences could not be explained by health insurance status, neighborhood poverty, or an early discontinuance of therapy.
- See “Black Women With Early HR+ Breast Cancer Have Shorter RFS and OS Vs White Women” by Hayley Virgil on the CancerNetwork website (May 19, 2022)
- See the abstract of the scientific paper “Assessment of Racial Disparity in Survival Outcomes for Early Hormone Receptor-Positive Breast Cancer After Adjusting for Insurance Status and Neighborhood Deprivation: A Post Hoc Analysis of a Randomized Clinical Trial” by Gelareh Sadigh et al.
